General Information of Drug Off-Target (DOT) (ID: OTJS5KTH)

DOT Name Nuclear RNA export factor 2 (NXF2)
Synonyms Cancer/testis antigen 39; CT39; TAP-like protein 2; TAPL-2
Gene Name NXF2
Related Disease
Acute leukaemia ( )
Carcinoma ( )
Cleft palate ( )
Colorectal carcinoma ( )
Isolated cleft palate ( )
Seminoma ( )
Testicular cancer ( )
Small lymphocytic lymphoma ( )
UniProt ID
NXF2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF02136 ; PF09162 ; PF03943
Sequence
MCSTLKKCGTYRTEVAECHDHGSTFQGRKKGGSSFRDNFDKRSCHYEHGGYERPPSHCQE
NDGSVEMRDVHKDQQLRHTPYSIRCERRMKWHSEDEIRITTWRNRKPPERKMSQNTQDGY
TRNWFKVTIPYGIKYDKAWLMNSIQSHCSDRFTPVDFHYVRNRACFFVQDASAASALKDV
SYKIYDDENQKICIFVNHSTAPYSVKNKLKPGQMEMLKLTMNKRYNVSQQALDLQNLRFD
PDLMGRDIDIILNRRNCMAATLKIIERNFPELLSLNLCNNKLYQLDGLSDITEKAPKVKT
LNLSKNKLESAWELGKVKGLKLEELWLEGNPLCSTFSDQSAYVSAIRDCFPKLLRLDGRE
LSAPVIVDIDSSETMKPCKENFTGSETLKHLVLQFLQQYYSIYDSGDRQGLLGAYHDEAC
FSLAIPFDPKDSAPSSLCKYFEDSRNMKTLKDPYLKGELLRRTKRDIVDSLSALPKTQHD
LSSILVDVWCQTERMLCFSVNGVFKEVEGQSQGSVLAFTRTFIATPGSSSSLCIVNDELF
VRDASPQETQSAFSIPVSTLSSSSEPSLSQEQQEMVQAFSAQSGMKLEWSQKCLQDNEWN
YTRAGQAFTMLQTEGKIPAEAFKQIS
Function Involved in the export of mRNA from the nucleus to the cytoplasm.
Tissue Specificity Expressed almost exclusively in testis. Also expressed in several cancers.
KEGG Pathway
Ribosome biogenesis in eukaryotes (hsa03008 )
Nucleocytoplasmic transport (hsa03013 )
mR. surveillance pathway (hsa03015 )
Amyotrophic lateral sclerosis (hsa05014 )
Influenza A (hsa05164 )
Herpes simplex virus 1 infection (hsa05168 )
Reactome Pathway
Transport of Mature mRNA derived from an Intron-Containing Transcript (R-HSA-159236 )

Molecular Interaction Atlas (MIA) of This DOT

8 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Acute leukaemia DISDQFDI Strong Biomarker [1]
Carcinoma DISH9F1N Strong Biomarker [2]
Cleft palate DIS6G5TF Strong Biomarker [3]
Colorectal carcinoma DIS5PYL0 Strong Biomarker [2]
Isolated cleft palate DISV80CD Strong Biomarker [3]
Seminoma DIS3J8LJ Strong Altered Expression [4]
Testicular cancer DIS6HNYO Strong Biomarker [1]
Small lymphocytic lymphoma DIS30POX moderate Biomarker [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Nuclear RNA export factor 2 (NXF2). [6]
------------------------------------------------------------------------------------
3 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Arsenic DMTL2Y1 Approved Arsenic decreases the expression of Nuclear RNA export factor 2 (NXF2). [7]
Decitabine DMQL8XJ Approved Decitabine increases the expression of Nuclear RNA export factor 2 (NXF2). [5]
Dihydrotestosterone DM3S8XC Phase 4 Dihydrotestosterone increases the expression of Nuclear RNA export factor 2 (NXF2). [9]
------------------------------------------------------------------------------------

References

1 The cancertestis antigen NXF2 is activated by the hypomethylating agent decitabine in acute leukemia cells in vitro and in vivo.Mol Med Rep. 2013 Nov;8(5):1549-55. doi: 10.3892/mmr.2013.1659. Epub 2013 Aug 28.
2 Cancer-testis antigen expression in digestive tract carcinomas: frequent expression in esophageal squamous cell carcinoma and its precursor lesions.Cancer Immunol Res. 2014 May;2(5):480-6. doi: 10.1158/2326-6066.CIR-13-0124. Epub 2013 Nov 11.
3 Respiratory failure, cleft palate and epilepsy in the mouse model of human Xq22.1 deletion syndrome.Hum Mol Genet. 2014 Jul 15;23(14):3823-9. doi: 10.1093/hmg/ddu095. Epub 2014 Feb 25.
4 Chromosome X-encoded cancer/testis antigens show distinctive expression patterns in developing gonads and in testicular seminoma.Hum Reprod. 2011 Dec;26(12):3232-43. doi: 10.1093/humrep/der330. Epub 2011 Oct 20.
5 Treatment of chronic lymphocytic leukemia with a hypomethylating agent induces expression of NXF2, an immunogenic cancer testis antigen. Clin Cancer Res. 2009 May 15;15(10):3406-15. doi: 10.1158/1078-0432.CCR-08-2099. Epub 2009 Apr 28.
6 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
7 Arsenic alters transcriptional responses to Pseudomonas aeruginosa infection and decreases antimicrobial defense of human airway epithelial cells. Toxicol Appl Pharmacol. 2017 Sep 15;331:154-163.
8 Treatment of chronic lymphocytic leukemia with a hypomethylating agent induces expression of NXF2, an immunogenic cancer testis antigen. Clin Cancer Res. 2009 May 15;15(10):3406-15. doi: 10.1158/1078-0432.CCR-08-2099. Epub 2009 Apr 28.
9 LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188.